EuroMedtech EBD Group EuroMedtech
Email this page Share this on LinkedIn Share this on Twitter

EuroMedtech™ 2014 Press Releases

May 15, 2014EuroMedtech™ 2014 reports an 82% increase in licensable assets and technologies brought to partner The sixth annual EuroMedtech partnering conference, held May 7–8, 2014, wrapped up in Linz, Austria last week. The event reported an 82% increase in licensing opportunities at the event, indicating a surge in medtech innovation and the increasing role of collaboration in medtech industry business strategies. "The event was buzzing with activity this year, with substan...  more ►

April 22, 2014EuroMedtech™ 2014 presenting companies bring cutting edge medical technologies to potential partners The sixth annual EuroMedtech partnering conference will be held May 7–8, 2014 in Linz, Austria. EuroMedtech is Europe's leading medical technology partnering conference, providing collaboration opportunities to medtech decision makers and investors. The Presenting Companies track provides a pipeline to innovative companies interested in partnering their technologies...  more ►

April 1, 2014EuroMedtech™ 2014 announces pre-conference business development workshop and May 8 special Diagnostics session The sixth annual EuroMedtech partnering conference will be held May 7–8, 2014 in Linz, Austria. EuroMedtech is Europe's leading medical technology partnering conference, providing collaboration opportunities to medtech decision makers and investors. A pre-conference Business Development Workshop entitled "Effective Innovation Portfolio Management for Medical Device ...  more ►

March 26, 2014Spotlight on Linz Business Facts A top European location for health technology: From blood sugar tests to wheelchairs, CT scanners to syringes—medical technology companies in Austria can be found in each and every specialized field of the sector. A thriving medical technology economy: A total of 433 companies in the Upper Austrian region can be related in one way or another to the field of medical techn...  more ►

February 6, 2014EuroMedtech™ 2014 brings leaders in medical device innovation to Linz, Austria this May The sixth annual EuroMedtech 2014 partnering conference will be held May 7–8, 2014 in Linz, Austria. EuroMedtech is Europe's leading medical technology partnering conference where participants engage with potential partners around in- and out-licensing of products and IP, financing and other collaborative programs. The 2013 event attracted 261 dealmakers from 191 comp...  more ►

partnering360® Blog

December 26, 2014 Find your next drug development partner in Paris Who doesn’t love Paris? Food, culture, fashion. The Eiffel Tower. But did you know that Paris is the number one region for developing startups in Western Europe, a leader in clinical research, innovation and more? Paris is one of the largest life science clusters in Europe, well known for its... more ►

December 23, 2014 Happy Holidays from EBD Group! 2014 has been an exciting year and we would like to thank you again for your participation in EBD Group Social Media. As a special thank you and to celebrate the holiday season, use the registration code GIVE2015 by January 15 for any of the below listed conferences and USD/EUR 50 of your... more ►

December 22, 2014 How Robust is the Biotech Rally? Guest post by Sara Jane Demy, CEO, Demy-Colton Life Science Advisors In 2014 the biopharmaceutical industry has surpassed virtually every financial benchmark imaginable. As the industry gets ready to gather in San Francisco next month, the question on everyone’s mind is, how long will it last?... more ►

December 19, 2014 How important are tax breaks in creating influential biotech clusters? The Federal Reserve Bank of San Francisco recently took an in-depth look at the impact that providing research and development tax breaks and biotech specific tax incentives has a direct impact on the quality of scientists in the region that move towards innovation in addition to providing economic... more ►

December 17, 2014 Key incentives for doing business in China: Interview with Dan Zhang of Fountain Medical Development Ltd. You hear it a lot: China is the next big thing for life science companies, and any company interested in establishing a presence in China would be tapping into a lucrative, growing market. And it’s true: China is now the world’s second largest healthcare market and is on track to be the largest... more ►

partnering360:Insight Latest headlines from partnering360:Insight

December 9, 2014 Interview with Dan Zhang, Foundation Medical Development partneringNEWS recently spoke with Dan Zhang, CEO of Fountain Medical Development, a CRO based mainly in China, but also with offices in the US, Taiwan, Hong Kong and South Korea. With China being the second largest healthcare market in the world, Zhang talks about the incentives for global companies to do business in China, and the ways in which FMD facilitates that. more ►

November 11, 2014 Bayer committed to Open Innovation and Collaborators The Head of Global Drug Discovery at Bayer HealthCare and a Member of the Executive Committee, Andreas Busch described the strategy underlying partnering efforts that he said have delivered a very significant value to patients as well as to shareholders. more ►

November 11, 2014 Merck Serono embraces partnering in all its forms Executive VP and Head of Global Research and Development at Merck Serono, Luciano Rossetti is also a Member of the Executive Committee who joined the company in late July this year. He offered to share with the audience a perspective from what he called a brief tenure. more ►

November 11, 2014 European biotech poised for acceleration David Loew is Senior VP for Commercial Operations in Europe at Sanofi. Rather than focusing on the company, Loew turned the spotlight on a wider concern for promoting a stronger environment for biotechs and start-ups in Europe. more ►

November 11, 2014 Transformational deals that shaped the industry in 2014 Led by moderator David Stubbs, the Managing Director for Inverness Advisors, the goal for the panel was to provide insights for transformational deals of the past year. The session was led off by a truly transformational deal that saw the USD 14.2 billion divestiture by Merck of its consumer healthcare business to Bayer HealthCare in May, 2014. The deal makes Bayer the second-biggest over-the-counter drug maker behind Johnson & Johnson. more ►

Arrow Up

See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD GmbH
Privacy Policy
Terms of Use
EuroMedtech EBD Group EuroMedtech